My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 332

    1.

    The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes.

    Chase HP, Lockspeiser T, Peery B, Shepherd M, MacKenzie T, Anderson J, Garg SK.

    Diabetes Care. 2001 Mar;24(3):430-4.PMID: 11289463 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.

    Alemzadeh R, Berhe T, Wyatt DT.

    Pediatrics. 2005 May;115(5):1320-4.PMID: 15867042 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.

    Holcombe JH, Zalani S, Arora VK, Mast CJ; Lispro in Adolescents Study Group.

    Clin Ther. 2002 Apr;24(4):629-38.PMID: 12017407 [PubMed - indexed for MEDLINE]Related articles

    4.

    [The insulin analog, Humalog, in discontinuous: from pharmacology to clinical use]

    Tauber JP.

    Diabetes Metab. 1997 Sep;23 Suppl 3:50-7. Review. French. PMID: 9410553 [PubMed - indexed for MEDLINE]Related articles

    5.

    Type 1 diabetes mellitus in early childhood: glycemic control and associated risk of hypoglycemic reactions.

    Lteif AN, Schwenk WF 2nd.

    Mayo Clin Proc. 1999 Mar;74(3):211-6.PMID: 10089987 [PubMed - indexed for MEDLINE]Related articles

    6.

    Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes.

    Braun D, Konrad D, Lang-Muritano M, Schoenle E.

    Pediatr Diabetes. 2008 Aug;9(4 Pt 2):382-7. Epub 2008 Mar 5.PMID: 18331413 [PubMed - indexed for MEDLINE]Related articles

    7.

    Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin.

    Chase HP, Dixon B, Pearson J, Fiallo-Scharer R, Walravens P, Klingensmith G, Rewers M, Garg SK.

    J Pediatr. 2003 Dec;143(6):737-40.PMID: 14657818 [PubMed - indexed for MEDLINE]Related articles

    8.

    Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group.

    Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, Ser N, Bougnères PF, Gillet P, Soskin S, Garandeau P, Stuckens C, Le luyer B, Jos J, Bony-Trifunovic H, Bertrand AM, Leturcq F, Lafuma A.

    Diabetes Care. 1998 Jul;21(7):1146-53.PMID: 9653610 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

    Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

    Clin Ther. 2001 Oct;23(10):1732-44.PMID: 11726007 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience.

    Dorchy H, Roggemans MP, Willems D.

    Diabetes Care. 1997 Jan;20(1):2-6.PMID: 9028684 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes.

    Hathout EH, Fujishige L, Geach J, Ischandar M, Maruo S, Mace JW.

    Diabetes Technol Ther. 2003;5(5):801-6.PMID: 14633345 [PubMed - indexed for MEDLINE]Related articles

    12.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    13.

    Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.

    Mullins P, Sharplin P, Yki-Jarvinen H, Riddle MC, Haring HU.

    Clin Ther. 2007 Aug;29(8):1607-19.PMID: 17919543 [PubMed - indexed for MEDLINE]Related articles

    14.

    [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?]

    Dorchy H.

    Arch Pediatr. 1994 Nov;1(11):970-81. French. PMID: 7834046 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program.

    Philis-Tsimikas A, Zhang Q, Walker C.

    Am J Ther. 2006 Nov-Dec;13(6):466-72.PMID: 17122525 [PubMed - indexed for MEDLINE]Related articles

    16.

    Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes.

    Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT.

    Pediatrics. 2004 Jul;114(1):e91-5.PMID: 15231979 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.

    [No authors listed]

    Diabetes. 1996 Oct;45(10):1289-98.PMID: 8826962 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment with the insulin analogue lispro in children and adolescents with type 1 diabetes mellitus: evaluation over a 3-year period.

    García L, Lamas C, Tuset MJ, Alonso M, Barrio R.

    Diabetes Nutr Metab. 2002 Feb;15(1):7-13.PMID: 11942742 [PubMed - indexed for MEDLINE]Related articles

    19.

    Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

    Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.

    Pediatr Diabetes. 2007 Jun;8(3):157-62.PMID: 17550426 [PubMed - indexed for MEDLINE]Related articles

    20.

    Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes.

    Brunelle BL, Llewelyn J, Anderson JH Jr, Gale EA, Koivisto VA.

    Diabetes Care. 1998 Oct;21(10):1726-31.PMID: 9773738 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity